ARTICLES BY THIS AUTHOR
- 8/16/2021
Zydus, Chemi partner on generic Lovenox launch
Enoxaparin Injection is used for prophylaxis of deep vein thrombosis in patients undergoing abdominal, hip or knee replacement surgery. - 8/16/2021
Lupin receives FDA tentative nod for generic Briviact
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients age 4 years old and older. - 8/16/2021
U.S. health officials expected to recommend 3rd COVID-19 vaccine booster
U.S. health experts are expected to recommend COVID-19 vaccine boosters for all Americans beginning eight months after they received their second dose of the vaccine, according to an AP report. - 8/15/2021
Jazz Pharmaceuticals receives FDA clearance for Xywav
Xywav is the first and only FDA-approved treatment for idiopathic hypersomnia, the company said. - 8/15/2021
Vgyaan gets FDA OK for generic Actigall, launches two generics
Vgyaan received the Food and Drug Administration’s approval for ursodiol capsules, and launched its Nadolol tablets and clomipramine hydrochloride capsules. - 8/15/2021
AAM commends President Biden’s ‘Build Back Better’ plan
The organization said it is looking forward to working with the administration to increase the $313 billion in savings that generic drugs generated in 2019, as well as build on the success of biosimilars in recent years. - 8/12/2021
Amber Specialty Pharmacy to dispense Kadmon’s Rezurock
Amber Specialty Pharmacy will support oncology and bone marrow transplant providers and patients throughout the country. - 8/12/2021
Alembic debuts generic Tricor
Alembic's fenofibrate capsules are available in dosage strengths of 67 mg, 134 mg, and 200 mg. - 8/12/2021
Genzyme receives FDA nod for Nexviazyme
The FDA's approval of Nexviazyme gives patients with Pompe disease another enzyme replacement therapy option for this rare disease. - 8/12/2021
FDA authorizes COVID booster for certain immunocompromised individuals
The FDA's action applies specifically to solid organ transplant recipients or those who are diagnosed with conditions that are considered to be equally immunocompromised.